General Information of the Compound
Compound ID
CP0298646
Compound Name
4-(2-{(1R,2R,3R)-3-Hydroxy-2-[(E)-(S)-3-hydroxy-4-(3-methoxymethyl-phenyl)-but-1-enyl]-5-oxo-cyclopentyl}-ethylsulfanyl)-butyric acid methyl ester
    Show/Hide
Synonyms
AE1-734
ONO-4819
ONO-4819.CD
ONO-4819CD
ONO-AE1-734
Rivenprost
    Show/Hide
Structure
Formula
C24H34O6S
Molecular Weight
450.597
Canonical SMILES
COCc1cccc(C[C@H](O)\C=C\[C@H]2[C@H](O)CC(=O)[C@@H]2CCSCCCC(=O)OC)c1
    Show/Hide
InChI
InChI=1S/C24H34O6S/c1-29-16-18-6-3-5-17(13-18)14-19(25)8-9-20-21(23(27)15-22(20)26)10-12-31-11-4-7-24(28)30-2/h3,5-6,8-9,13,19-22,25-26H,4,7,10-12,14-16H2,1-2H3/b9-8+/t19-,20-,21-,22-/m1/s1
    Show/Hide
InChIKey
FBQUXLIJKPWCAO-AZIFJQEOSA-N
CAS
256382-08-8
Physicochemical Property
logP
2.9352
Rotatable Bonds
13
Heavy Atom Count
31
Polar Areas
93.06
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
7
Complexity
31

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9803828
SID: 49684223
ChEMBL ID
CHEMBL303960
DrugBank ID
DB16315
Clinical Information about the Compound
Drug 1 ( ONO-4819 )
Drug Name ONO-4819
Company Novartis
Indication
Fracture
Discontinued in Phase 2
Target(s)
Prostaglandin E2 receptor EP4 (PTGER4)
Agonist